Almitas Capital’s Metagenomi Therapeutics MGX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGX
Almitas Capital's MGX Position: Q3 2026 in Review
Almitas Capital opened a new position in Metagenomi Therapeutics (MGX) in Q3 2026: 282,308 shares worth $299K. The stake represents 0.07% of the portfolio and ranks #112 among its holdings.
44 funds tracked by Wall St. Rank hold MGX as of Q3 2026.
- Almitas Capital held 282,308 shares of Metagenomi Therapeutics worth $299K as of Q3 2026.
- Metagenomi Therapeutics was a new Almitas Capital position in Q3 2026.
- Metagenomi Therapeutics made up 0.07% of Almitas Capital's portfolio in Q3 2026, its #112 holding.
- 44 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q3 2026.
Based on Almitas Capital's 13F filing for Q3 2026, filed 17 Nov 2026.